GUADAGNI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.647
AS - Asia 4.673
EU - Europa 764
SA - Sud America 263
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 81
OC - Oceania 16
Totale 13.623
Nazione #
US - Stati Uniti d'America 6.601
TR - Turchia 2.400
CN - Cina 1.065
CA - Canada 1.003
SG - Singapore 914
IT - Italia 262
BR - Brasile 234
EU - Europa 177
IE - Irlanda 98
IN - India 87
DE - Germania 77
GB - Regno Unito 58
HK - Hong Kong 42
FI - Finlandia 35
VN - Vietnam 31
RU - Federazione Russa 30
MX - Messico 29
SC - Seychelles 29
FR - Francia 28
PL - Polonia 28
ZA - Sudafrica 28
ES - Italia 26
BD - Bangladesh 25
JP - Giappone 25
NL - Olanda 20
UA - Ucraina 20
RO - Romania 16
SE - Svezia 16
AU - Australia 13
ID - Indonesia 13
IQ - Iraq 13
LT - Lituania 12
SA - Arabia Saudita 11
PK - Pakistan 8
CL - Cile 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
DK - Danimarca 5
EC - Ecuador 5
BB - Barbados 4
CH - Svizzera 4
GR - Grecia 4
KE - Kenya 4
MA - Marocco 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
CZ - Repubblica Ceca 3
EG - Egitto 3
HU - Ungheria 3
KR - Corea 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NA - Namibia 1
NE - Niger 1
NP - Nepal 1
NR - Nauru 1
PA - Panama 1
SI - Slovenia 1
TJ - Tagikistan 1
Totale 13.622
Città #
Kocaeli 2.103
San Mateo 1.619
Dallas 968
Toronto 960
Wilmington 464
Houston 425
Santa Clara 364
Lawrence 322
Princeton 322
Beijing 287
Singapore 287
Ashburn 217
Chandler 210
Seattle 132
Fairfield 129
Los Angeles 101
Woodbridge 101
Shanghai 99
Guangzhou 66
Cambridge 55
Rome 46
Brooklyn 38
Hong Kong 37
Dublin 35
Shenzhen 32
Helsinki 31
Redwood City 31
The Dalles 26
New York 25
Warsaw 24
Chicago 23
São Paulo 23
Columbus 21
Tokyo 21
Johannesburg 19
Munich 17
Saint Petersburg 17
Boston 16
Wuhan 16
Quanzhou 15
Redmond 15
Mexico City 14
Milan 14
Council Bluffs 13
Jiaxing 13
London 13
Montreal 13
Rui'an 12
Washington 12
Xi'an 12
Nanjing 11
Pune 11
Wuxi 11
Chennai 10
Hanoi 10
Kyiv 10
Ankara 9
Atlanta 9
Pesaro 9
Stockholm 9
Bandung 8
Bari 8
Dongyang 8
Frankfurt am Main 8
Jinhua 8
Mumbai 8
Phoenix 8
San Francisco 8
Taizhou 8
Amsterdam 7
Ho Chi Minh City 7
Nantong 7
Philadelphia 7
Vicenza 7
Xuzhou 7
Zhengzhou 7
Belo Horizonte 6
Changsha 6
Hefei 6
Rockville 6
Charlotte 5
Denver 5
Dhaka 5
Jinan 5
Qingdao 5
Rio de Janeiro 5
Riyadh 5
Aarhus 4
Brescia 4
Cleveland 4
Hangzhou 4
Hyderabad 4
Manchester 4
Nairobi 4
Naples 4
Shijiazhuang 4
Vancouver 4
West Jordan 4
Zibo 4
Austin 3
Totale 10.205
Nome #
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 115
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 109
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 101
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience 97
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 85
Activation of blood coagulation in breast cancer - relationship to clinical outcome 80
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 79
TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER 78
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments 78
Aging: an important risk factor in chemotherapy-associated vascular diseases 77
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review 77
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 76
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 72
CARCINOEMBRYONIC ANTIGEN REGULATION IN HUMAN COLORECTAL TUMOR-CELLS BY A SITE-SELECTIVE CYCLIC-AMP ANALOG - A COMPARISON WITH INTERFERON-GAMMA 71
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 70
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 69
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 69
A NOVEL NONSENSE MUTATION IN KRAS GENE 68
BIOLOGIC EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN COLORECTAL-CANCER .1 64
A Simple and Effective Method to Analyze Membrane Proteins by SDS-PAGE and MALDI Mass Spectrometry 64
A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS 64
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 64
An AT-Rich Region in the APC Gene May Cause Misinterpretation of Familial Adenomatous Polyposis Molecular Screening 64
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells 63
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 60
Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection 60
Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression 58
Correlation between soluble CD40 ligand, VEGF plasma levels and haemostatic activation in non-small cell lung cancer (NSCLC) 57
"Proteomineering" or not? The debate on biomarker discovery in sera continues 57
“Personal and sensitive data in the e-health-IoT universe” 57
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 56
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo 56
Association between carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content of colorectal cancer 55
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers 55
Role of interleukin-6 in the diagnosis of acute aortic dissection 55
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 55
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 55
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 55
MUTATIONAL ANALYSIS IN INHERITED BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY REGINA ELENA CANCER INSTITUTE OF ROME, ITALY 55
In vitro interactions between blood platelets and human colorectal tumor cells 54
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 54
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 54
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 54
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')(2) (F023C5) in CEA serum-negative colorectal cancer patients 53
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 53
TARGETING ANTIBODIES TO LIVE TUMOR-TISSUE IN 3-D HISTOCULTURE 53
BIOLOGIC AND CLINICAL CORRELATIONS AMONG PLOIDY, CELL-KINETICS, AND THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 TISSUE EXPRESSION IN COLORECTAL-CANCER - PRELIMINARY FINDINGS 53
Age-related reduction of cerebral ischemic preconditioning: myth or reality? 53
Is CEA serum measurement useful in monitoring breast cancer patients? 52
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation 52
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 52
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 52
PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability 52
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 52
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 52
SERUM LEPTIN LEVELS IN COLORECTAL CANCER PATIENTS 51
Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients 51
PLATELET PROAGGREGATING ACTIVITY OF HUMAN COLORECTAL TUMOR-CELL LINES DOES NOT CORRELATE WITH THE DEGREE OF DIFFERENTIATION 51
EVALUATION OF TAG-72 (CA-72-4) SERUM MARKER IN PRIMARY DIAGNOSIS IN OVARIAN-CANCER - A COMPARISON WITH CA-125 51
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 51
Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells 51
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 51
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 51
Metabolic Syndrome (MetS) in Metastatic (m) Colorectal Cancer (CRC) Patients (pts) Might Delay the Onset of Cachexia 50
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 50
Sentinel lymphadenectomy in cutaneous melanoma 50
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 50
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 50
TUMOR-ASSOCIATED GLYCOPROTEIN-72 SERUM LEVELS COMPLEMENT CARCINOEMBRYONIC ANTIGEN LEVELS IN MONITORING PATIENTS WITH GASTROINTESTINAL CARCINOMA - A LONGITUDINAL-STUDY 50
Machine learning approach to predict medication overuse in migraine patients 50
The insulin-glucose axis in breast cancer - relationship to clinical outcome 49
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 49
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 49
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 49
Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group 49
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation 49
Plasma Plasminogen Activator Inhibitor-1 (PAI-1) Levels in Breast Cancer - Relationship with Clinical Outcome 49
BRCA1 and BRCA2 mutational analysis in inherited breast/ovarian cancer patients from central Italy 48
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 48
Vascular endothelial growth factor levels in melanoma Relationship with coagulation and platelet activation markers 48
Fibrinolysis components in colorectal carcinoma 48
Plasma von Willebrand factor antigen levels in non-small cell lung cancer patients 48
CA-72-4 MEASUREMENT OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72) AS A SERUM MARKER IN THE MANAGEMENT OF GASTRIC-CARCINOMA 48
Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus 48
Enhanced expression of LINE-1 encoded ORF2 protein in early stages of colon and prostate transformation 48
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 48
Platelet activation and low-grade inflammation in hypertensives with or without microalbuminuria 48
Artificial intelligence for cancer-associated thrombosis risk assessment 48
Evaluation of the clinical impact of serum tumor markers in gastric cancer. A prospective longitudinal study 47
Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review) 47
Biomarkers of platelet activation in acute coronary syndromes 47
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 47
IS THE CD54 PROTEIN (ICAM-1) INVOLVED IN PLATELET-TUMOR CELL-INTERACTION 47
Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters 47
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 47
Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas 47
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 47
Evaluation of the Clinical Impact of Serum Tumor Markers in Colorectal Cancer A Prospective Longitudinal Study 46
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients 46
Plasma VEGF levels correlate with haemostatic activation in HCC patients 46
Totale 5.735
Categoria #
all - tutte 149.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.379


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.948 0 0 41 3 105 148 95 55 99 59 2.113 230
2021/20223.140 19 961 966 5 4 6 348 352 47 389 5 38
2022/20231.172 703 24 17 70 49 13 7 53 41 81 110 4
2023/2024710 6 2 21 152 36 48 15 35 0 63 5 327
2024/20252.898 158 642 144 110 162 499 197 145 325 20 80 416
2025/20261.721 534 751 436 0 0 0 0 0 0 0 0 0
Totale 14.090